Characterization of novel MPS1 inhibitors with preclinical anticancer activity. (Record no. 22993259)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02025 a2200625 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516163750.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201407s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1476-5403 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1038/cdd.2013.105 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Jemaà, M |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20140703 |
245 00 - TITLE STATEMENT | |
Title | Characterization of novel MPS1 inhibitors with preclinical anticancer activity. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Cell death and differentiation |
Date of publication, distribution, etc. | Nov 2013 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1532-45 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Apoptosis |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Cycle |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Cycle Proteins |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Synergism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HeLa Cells |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice, Nude |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Paclitaxel |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein Kinase Inhibitors |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein Serine-Threonine Kinases |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein-Tyrosine Kinases |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Random Allocation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Transfection |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Galluzzi, L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kepp, O |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Senovilla, L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Brands, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Boemer, U |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Koppitz, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lienau, P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Prechtl, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schulze, V |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Siemeister, G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wengner, A M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mumberg, D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ziegelbauer, K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Abrieu, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Castedo, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vitale, I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kroemer, G |
773 0# - HOST ITEM ENTRY | |
Title | Cell death and differentiation |
Related parts | vol. 20 |
-- | no. 11 |
-- | p. 1532-45 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1038/cdd.2013.105">https://doi.org/10.1038/cdd.2013.105</a> |
Public note | Available from publisher's website |
No items available.